Lung Cancer Research Foundation
- Company typePrivate
- Founded2000
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
Lung Cancer Research Foundation firmographics
Firmographics- Name
- Lung Cancer Research Foundation
- Legal name
- Lung Cancer Research Foundation
- Website
- https://lungcancerresearchfoundation.org
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Lung Cancer Research Foundation industry classification
Industry- Product category
- Cancer Research Nonprofit
- NAICS
- Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
- akta.pro secondary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
Keywords
Where Lung Cancer Research Foundation is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Lung Cancer Research Foundation business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Individual Donations: Direct charitable contributions from individuals supporting lung cancer research
- Memorial and Honor Gifts: Gifts made in honor or memory of loved ones, including In Memory Wall plaque purchases at $500, $1,000, and $5,000+ levels
- Bequests and Planned Giving: Will bequests, trusts, life insurance, retirement plans facilitated through FreeWill partnership
- IRA Charitable Distributions: Qualified charitable distributions from IRAs for donors 70.5+ years old
- Donor-Advised Funds: Grants from DAFs with automated linking for convenience
- Securities and Stock Donations: Appreciated stock donations avoiding capital gains tax
- Cryptocurrency Donations: Accepts Ethereum, Bitcoin, and other cryptocurrencies
- Workplace Giving: Payroll deduction programs and Combined Federal Campaign (CFC #42372) for federal employees
- Corporate Partnerships and Sponsorship: Pharmaceutical and healthcare company sponsorships for events, programs, and educational materials
- Event Revenue: Registration fees and fundraising from walks, galas, and endurance race teams
Go-to-market motion1 record
Distribution channels7 records
Marketing channels11 records
Lung Cancer Research Foundation product offering
Product offeringCore offering
Lung Cancer Research Foundation (LCRF) is a 501(c)(3) nonprofit that funds innovative lung cancer research through competitive grant programs (450 grants totaling nearly $53 million) and delivers patient and caregiver support services including a toll-free Lung Cancer Support Line, free educational materials on biomarker testing, clinical trials and immunotherapy, clinical trial matching via Carebox, and Together Separately educational livestreams. The organization also operates community fundraising events such as Free to Breathe Walks, Team LCRF endurance teams, and an annual Gala and Scientific Symposium.
Product overview
Lung Cancer Research Foundation (LCRF) is a nonprofit organization focused on funding innovative lung cancer research and supporting patients and caregivers. The organization operates a multi-pronged service model consisting of: (1) Patient support services including a toll-free Lung Cancer Support Line staffed by a licensed clinical social worker with interpretation in 200+ languages; (2) Free educational programs including Together Separately Livestreams featuring expert discussions on treatment advances; (3) Patient/caregiver educational materials covering biomarker testing, clinical trials, immunotherapy, and living with lung cancer available in English and Spanish; (4) Fundraising events including Free to Breathe Walks (Kansas City, Chicago, Anywhere), Team LCRF endurance events, and Free to Breathe Your Way individual fundraisers; (5) Clinical trial matching through Carebox partnership; (6) Continuing education for medical professionals through Medlive Cancer; (7) Planned giving programs through FreeWill partnership; and (8) Community awareness initiatives including Know Your Risk programs for underserved populations.
Differentiator
Problem solved
Functional benefit
Products and services
- Lung Cancer Support Line Toll-free support line (844-835-4325) staffed by a licensed clinical social worker, available Monday-Friday 9am-5pm ET, providing personalized resource navigation, financial assistance referrals, transportation and lodging help, clinical trial guidance, and peer connections for lung cancer patients and caregivers, with interpretation in 200+ languages.
- Patient Educational Materials Free printed and digital educational booklets covering Living with Lung Cancer, Biomarker Testing, Clinical Trials, Immunotherapy, and caregiving. Available in English and Spanish with free shipping within the U.S., designed for patients and caregivers.
- Clinical Trial Matching (via Carebox) Partnership service that lets patients, caregivers, and healthcare professionals search and match to lung cancer clinical trials through a short questionnaire covering diagnosis, stage, and treatment history.
- Free to Breathe Walk Community walk events including the Kansas City Walk, Chicago Walk, and Anywhere Walk that bring supporters together to raise awareness and funds for lung cancer research.
- Free to Breathe Your Way Individual/community fundraising program enabling supporters to turn any activity (golfing, bowling, baking, music, yoga, parties) into a personal fundraiser for lung cancer research.
- Team LCRF Endurance Events Charity partnership program for endurance races including TCS New York City Marathon, United Airlines NYC Half, and Five Boro Bike Tour, letting participants meet fitness goals while fundraising for lung cancer research.
- Together Separately Livestreams Educational webinar series featuring expert moderators and guest speakers discussing lung cancer treatment navigation, the latest research findings, and conference recaps from ASCO and WCLC, with a companion Facebook community group.
- Comprehensive Biomarker Testing Education Educational resource covering biomarker testing, oncogenic driver mutations, immunotherapy biomarkers, and targeted therapies for NSCLC treatment, including information on KRAS, EGFR, ALK, and other mutations with FDA-approved treatment options.
- Patient and Caregiver Kit Complimentary tote bag filled with supportive items and resources for patients and caregivers on their lung cancer journey, distributed free of charge.
- Healthcare Provider Kit Kit containing one copy of each LCRF resource, enabling healthcare providers to evaluate which LCRF materials best suit the needs of their lung cancer patients for clinic distribution.
- Planned Giving and Legacy Programs Gift planning services including bequests, IRA charitable distributions, Donor-Advised Fund grants, gifts of appreciated securities, and cryptocurrency donations, facilitated through the FreeWill partnership.
- Continuing Education for Medical Professionals Free online continuing education opportunities for oncologists, pulmonologists, nurses, and other medical professionals treating lung cancer, offered through partnership with Medlive Cancer.
- Know Your Risk Program Awareness initiative increasing understanding of lung cancer risk in Black and Hispanic American populations through culturally tailored educational resources and outreach materials.
- In Memory Wall Online virtual memorial wall honoring lives lost to lung cancer, offering digital plaques at $500, $1,000, and $5,000+ giving levels as memorial tributes.
- LCRF Scientific Symposium Annual scientific symposium held during Lung Cancer Awareness Month featuring State of the Science updates, emerging research presentations, and the Lung Cancer Mutation Consortium.
Quantifiable outcome
- 87 cents of every dollar goes directly to funding mission-related programs and services
- +2 more outcomes
Companies that use Lung Cancer Research Foundation
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles6 records
Lung Cancer Research Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Lung Cancer Research Foundation partnerships and signals
Strategic signalPartnerships
25 partnerships are on record, tiered core and minor.
- AstraZenecacorePharmaceutical research partner supporting LCRF's mission to fund innovative lung cancer research. AstraZeneca is one of LCRF's key corporate research partners providing funding for research grants and programs.
- Boehringer IngelheimcorePharmaceutical research partner and sponsor of LCRF events including Free to Breathe walks and Together Separately livestreams. Supports lung cancer research funding and patient education programs.
- BayercoreCorporate research partner and event sponsor, supporting LCRF's Free to Breathe events and Women and Lung Cancer Program. Provides funding for research initiatives and patient resources.
- Foundation MedicinecoreMolecular information company providing biomarker testing support. Sponsor of educational materials on comprehensive biomarker testing for lung cancer, helping patients access tumor testing.
- Merck & Co., Inc.coreMajor pharmaceutical sponsor supporting LCRF programs including the Lung Cancer Support Line (funding interpretation services), Free to Breathe events, and Women and Lung Cancer Program.
- Pfizer OncologycorePresenting sponsor for Free to Breathe national events, supporting lung cancer awareness walks and fundraising initiatives across the country.
- Johnson & JohnsoncoreNational sponsor for Free to Breathe events and supporter of Healthcare Provider Kits through Johnson & Johnson Foundation funding.
- Summit TherapeuticscorePharmaceutical sponsor supporting Free to Breathe events and biomarker testing educational materials, advancing lung cancer research awareness.
- AbbViecorePresenting sponsor for Free to Breathe Chicago Walk and sponsor of Together Separately livestreams, supporting patient education and community engagement.
- Medlive CancerminorPartner providing free online continuing education opportunities for medical professionals in partnership with LCRF.
- CareboxminorClinical trial matching partnership allowing LCRF to provide patients with easy search and match to lung cancer clinical trials through a short questionnaire.
- Cancer Hope NetworkminorPartnership providing lung cancer patients and caregivers with trained volunteer survivors for peer support and connection.
- BioNTechminorSponsor of LCRF's Lung Cancer Support Line, helping fund free support services for patients and caregivers.
- NuvalentminorSponsor of LCRF's Lung Cancer Support Line supporting free patient support services.
- Taiho OncologyminorSponsor of LCRF's Lung Cancer Support Line and educational materials on biomarker testing.
- RegeneronminorSponsor of Together Separately livestream webinar series providing educational content to lung cancer community.
- Bristol Myers SquibbminorSponsor of Together Separately livestream educational series on lung cancer research and treatment.
- Susan Wojcicki FoundationminorCo-presenter of special edition Together Separately livestream on heritable genetics in lung cancer, in partnership with LCRF and other organizations.
- GenentechminorSponsor of Together Separately livestream educational series on lung cancer.
- FreeWillminorOnline gift planning partner providing free will-planning resource for donors to include LCRF in their estate planning.
- MintedminorDesign marketplace charity partner where purchases using code FUNDRAISELCRF donate 10% of purchase price to LCRF and provide 20% discount to supporters.
- International Association for the Study of Lung Cancer (IASLC)coreResearch partner supporting lung cancer research initiatives and professional education in the lung cancer field.
- Eli Lilly and CompanycoreSponsor of Healthcare Provider Kits and biomarker testing educational materials including the Lilly Lung Cancer NGS Program for no-cost comprehensive biomarker testing.
- GileadminorSponsor of educational materials on biomarker testing for lung cancer.
- Takeda OncologyminorSponsor of educational materials on biomarker testing for lung cancer.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Lung Cancer Research Foundation competitors and assessment
Company assessmentDirect peers
- V Foundation for Cancer Research: Disease-specific (all-cancer) research grantmaking nonprofit with a similar high-impact, translational-research funding model. Competes for major-donor and corporate-sponsored cancer research dollars.
- Prevent Cancer Foundation: Cancer-specific research and education nonprofit with a comparable mix of research grants, public awareness campaigns, and patient education programs. Operates at a similar scale and competes in the same federal-employee CFC workplace-giving space.
- LUNGevity Foundation: Direct peer focused specifically on lung cancer research funding, patient education, and survivorship programs. Competes head-to-head with LCRF for research grant applications, donor dollars, and corporate research sponsorships.
- Stand Up To Cancer: High-profile collaborative cancer research funder using a similar translational-research grant model. Competes for corporate sponsorships (pharma, media partners) and celebrity-driven fundraising attention.
- National Foundation for Cancer Research: Cancer-specific research grantmaking nonprofit with a similar donor-funded translational-research model, including planned-giving, memorial giving, and international research collaborations.
- GO2 Foundation for Lung Cancer: The closest direct peer: also a U.S. nonprofit dedicated to lung cancer, combining research funding, patient support, and advocacy. Formed from the merger of the Bonnie J. Addario Lung Cancer Foundation and the Lung Cancer Alliance, competing for the same donors, sponsors, and researchers as LCRF.
Others
- Susan G. Komen: While focused on breast cancer rather than lung cancer, Komen serves as the gold-standard disease-specific research nonprofit model — analogous structure (research grants + patient support + walks + corporate sponsorships + transparency ratings) that defines the competitive fundraising landscape LCRF operates within.
Broad incumbents
- American Lung Association: A larger, established nonprofit covering all lung diseases (not just cancer). Funds lung cancer research alongside COPD, asthma, and tobacco control, with much broader brand recognition and a deeper corporate-giving infrastructure that overlaps LCRF's donor pool.
- American Cancer Society: The largest U.S. cancer nonprofit, funding research across all cancer types including lung cancer. Operates a national research grants program that competes directly with LCRF for investigator applications and major-donor philanthropy.
Emerging players
- Mesothelioma Applied Research Foundation: Smaller, disease-specific research nonprofit focused on mesothelioma, a lung-related cancer. Overlaps with LCRF in research funding approach, biomarker/clinical trial education, and patient advocacy niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Lung Cancer Research Foundation social profiles
Digital presenceLung Cancer Research Foundation compliance and trust
Trust signalCompliance3 records
Lung Cancer Research Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lung Cancer Research Foundation leadership team
Management profileNumber of profiles
Profiles8 records
Lung Cancer Research Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lung Cancer Research Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lung Cancer Research Foundation
What does Lung Cancer Research Foundation do?
Lung Cancer Research Foundation (LCRF) is a 501(c)(3) nonprofit that funds innovative lung cancer research through competitive grant programs (450 grants totaling nearly $53 million) and delivers patient and caregiver support services including a toll-free Lung Cancer Support Line, free educational materials on biomarker testing, clinical trials and immunotherapy, clinical trial matching via Carebox, and Together Separately educational livestreams. The organization also operates community fundraising events such as Free to Breathe Walks, Team LCRF endurance teams, and an annual Gala and Scientific Symposium.
Is Lung Cancer Research Foundation a public or private company?
Lung Cancer Research Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Lung Cancer Research Foundation founded?
Lung Cancer Research Foundation was founded in 2000. It employs 11 to 50 people.
Where is Lung Cancer Research Foundation based?
Lung Cancer Research Foundation is headquartered in New York, United States, in the North America region.
How does Lung Cancer Research Foundation make money?
Ten revenue lines are on record. Individual Donations are the primary driver. The others are memorial and Honor Gifts, bequests and Planned Giving, IRA Charitable Distributions, donor-Advised Funds, securities and Stock Donations, cryptocurrency Donations, workplace Giving, corporate Partnerships and Sponsorship and event Revenue.
Who are Lung Cancer Research Foundation's main competitors?
Direct peers on record are V Foundation for Cancer Research, Prevent Cancer Foundation, LUNGevity Foundation, Stand Up To Cancer, National Foundation for Cancer Research and GO2 Foundation for Lung Cancer. Susan G. Komen is listed as an others. Broad incumbents are American Lung Association and American Cancer Society. Mesothelioma Applied Research Foundation is listed as an emerging player.
Does Lung Cancer Research Foundation have an API?
No public API is recorded for Lung Cancer Research Foundation.
What industry is Lung Cancer Research Foundation in?
Lung Cancer Research Foundation's product category is Cancer Research Nonprofit. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8000.